Analytical Data
-
Gene name
DEFB106A
- Application
-
Alternative Names
Beta-defensin 6 (BD-6)(DEFB-6)(cBD-6)
-
Species
Chimpanzee
-
Source
E. coli
-
Tag
N- His-KSI
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5IAB3
-
Expression Region
21-65aa
-
Molecular Weight
20.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DEFB106A, a member of the defensin family of antimicrobial peptides, has garnered significant attention due to its potential roles in innate immunity and its involvement in various physiological and pathological processes. This protein is predominantly expressed in human epithelial tissues, particularly in the respiratory and reproductive tracts, where it plays a crucial role in host defense against a wide range of pathogens, including bacteria and viruses. Research into DEFB106A has increased as studies reveal its ability to modulate inflammatory responses, contribute to wound healing, and maintain microbial homeostasis. Additionally, its association with conditions such as allergies, asthma, and certain types of cancer highlights its importance in health and disease. The recombinant expression of DEFB106A facilitates detailed investigations into its structural and functional properties, enabling scientists to explore its therapeutic potential. By using techniques such as recombinant DNA technology, researchers can produce DEFB106A in sufficient quantities for functional assays, antibody production, and further studies into its mechanism of action. Understanding DEFB106A’s interactions at the molecular level is essential for developing novel strategies for disease treatment and prevention, making it a subject of growing interest in immunology and biomedicine.
